Uzbekistan and South Korea held discussions on the prospects of deepening interaction in the pharmaceutical and cosmeceutical sectors. According to the statement from the Agency for the Development of the Medical and Pharmaceutical Industry, the parties considered the possibility of launching joint production projects directly on the territory of Uzbekistan.
The delegation led by Abdullah Azizov, Director of the Agency for the Development of the Medical and Pharmaceutical Industry, participated in the Uzbekistan-Korea Business Forum. At the forum, representatives of the South Korean government, major corporations, and business circles discussed the further development of trade, economic, and investment partnership between the two countries.
During the event, separate negotiations took place with the management of MIBA, which operates in the pharmaceutical and cosmetic industries. The Uzbek side presented opportunities for developing the pharmaceutical and cosmeceutical industry, as well as the potential of the BioPharma City cluster and available investment incentives.
Participants discussed the likelihood of creating joint production facilities in Uzbekistan, attracting capital investments, and implementing modern technologies. Furthermore, they reviewed new areas for cooperation and investment initiatives.
After the meetings concluded, MIBA's management was invited to visit Uzbekistan to discuss specific areas of joint work in detail.
During a video conference held on August 11, 2026, Uzbekistan and Denmark discussed the potential for joint work in the field of pharmaceutical product regulation. This was reported by the Center for Pharmaceutical Product Safety.
Representatives from the Center for Pharmaceutical Product Safety of Uzbekistan, the Danish Medicines Agency (DKMA), and the Embassy of Uzbekistan in Sweden participated in the meeting. The Uzbek side presented information about its center's activities, its powers, and its main areas of work.
The main focus of the discussions was on state registration and inspection of medicines, pharmacovigilance, quality control of drugs, laboratory activities, ensuring the safety of pharmaceutical products, and implementing international standards.
Participants emphasized the importance of modern approaches and compliance with international norms in pharmaceutical regulation, as well as the importance of knowledge exchange and raising the professional level between regulatory bodies.
The Danish Medicines Agency acts as the state body of Denmark responsible for regulating medicines and medical devices. Its duties include licensing and inspecting pharmaceutical companies, registering medicines, conducting clinical trials, managing pharmacovigilance, and monitoring the safety of medical devices.
Special emphasis was placed on practical ways of bilateral interaction. The parties studied possibilities for direct expert-level participation, sharing experience in regulatory practice, holding training seminars and professional development programs. The possibility of joint projects aimed at improving the qualifications of pharmaceutical industry specialists was also discussed.
During the working visit of the Director of the Pharmaceutical Industry Development Agency, Abdulla Azizov, to India, Uzbekistan and India discussed opportunities to deepen interaction in the field of pharmaceuticals.
The meeting took place with India's Minister of Trade and Industry, Piyush Goyal, as part of the Uzbek delegation led by the Minister of Investment, Industry and Trade, Laziz Kudratov.
The parties reviewed issues of further development of trade, economic, and investment cooperation, as well as increasing bilateral trade turnover, expanding industrial partnership, and supporting joint investment projects.
The negotiators paid special attention to interaction in the pharmaceutical field. They discussed prospects for joint production of medicines and medical devices, technology transfer, scientific research, implementation of innovative developments, and realization of high value-added projects.
At the end of the meeting, the parties reaffirmed their commitment to strengthening the strategic partnership between Uzbekistan and India, expanding business contacts, and continuing joint work on promising projects.
Representatives of state bodies and business circles from Uzbekistan and Kyrgyzstan discussed opportunities for partnership in the field of pharmaceuticals, industrial cooperation, and joint investment projects. The event took place as part of the Uzbekistan-Kyrgyzstan Business Forum held in Bishkek.
A panel session dedicated to healthcare and pharmaceuticals was organized within this forum. During the session, a representative of the Agency for the Development of Medical and Pharmaceutical Industry of Uzbekistan presented information on the investment potential of the country's pharmaceutical sector.
Forum participants received information about current investment projects being implemented in Uzbekistan, as well as about state support measures, the investment climate, and opportunities provided by free economic zones. Furthermore, reforms aimed at developing the pharmaceutical industry were presented.
During the discussion, the parties also exchanged views on expanding cooperation between Uzbekistan and Kyrgyzstan in the field of drug production, technology transfer, and the implementation of joint initiatives.
